Display # 
Title Author Hits
Could Time to Approval be Secondary? Written by Giora Davidai, MD 540
Quality with Good Intent Written by Julie Gerlach 488
Winter 1-2017 Newsletter Written by Kristi Hultberg 836
Presentation - Ed Allera, Esq. and Barbara Binzk Blumenfeld, Ph.D., M.A., Esq. Written by Ed Allera, Barbara Binzak 734
Newsletters Written by Kristi Hultberg 408
Hypoglycemia Evaluation and Reporting in Diabetes: Importance for the Development of New Therapies Written by David C. Klonoff et al. 1037
Round Table Discussion - Friday 1/20/17 Written by Dr. Fleming 538
Keys to Regulatory Operations Success Written by Sue Manley 499
FDA E-Submission Written by Steve Casey 528
Regulatory Perspectives From FDA Staff Written by Brian Harvey 735